Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)
NCT00907478
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
169
Enrollment
INDUSTRY
Sponsor class
Conditions
Thrombocytopenia
Idiopathic Thrombocytopenic Purpura
Interventions
BIOLOGICAL:
romiplostim
Sponsor
Amgen